Kevin C Knightly
CIK 1350000 · View on SEC EDGAR ↗
First SEC filing: Oct. 5, 2016 · Latest: Oct. 5, 2016
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 3, 2016 | IQV | A | 23,040 | — | — | 23,040 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 3, 2016 | IQV | A | 23,040 | — | — | 23,040 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 3, 2016 | IQV | A | 18,566 | — | — | 18,566 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 3, 2016 | IQV | A | 10,207 | — | — | 10,207 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 3, 2016 | IQV | A | 8,284 | — | — | 8,284 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 3, 2016 | IQV | A | 46,080 | — | — | 46,080 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 3, 2016 | IQV | A | 26,826 | — | — | 26,826 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 3, 2016 | IQV | Employee Stock Option (Right to Buy) | Common Stock (23,040) | $15.11 | March 15, 2020 | 23,040 | Acquired |
| Oct. 3, 2016 | IQV | Employee Stock Option (Right to Buy) | Common Stock (23,040) | $8.34 | March 15, 2020 | 23,040 | Acquired |
| Oct. 3, 2016 | IQV | Phantom Stock | Common Stock (18,566) | — | — | 18,566 | Acquired |
| Oct. 3, 2016 | IQV | Stock Appreciation Right | Common Stock (10,207) | $59.90 | Feb. 2, 2026 | 10,207 | Acquired |
| Oct. 3, 2016 | IQV | Stock Appreciation Right | Common Stock (8,284) | $65.16 | Feb. 10, 2025 | 8,284 | Acquired |
| Oct. 3, 2016 | IQV | Employee Stock Option (Right to Buy) | Common Stock (46,080) | $26.05 | March 15, 2020 | 46,080 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $517,500 | — | — | — | $575,000 | $57,865 | $33,351 | $2,190,182 |
| 2017 | $487,500 | — | — | — | $600,000 | $144,918 | $30,532 | $1,989,213 |
| 2016 | $119,399 | — | — | — | $500,000 | $2,582 | $16,858 | $638,839 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.